HighMark Wealth Management’s Lyra Therapeutics LYRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-80	Closed	-$20K	–	555
2022 Q3	$20K	Hold	80	–	–	0.02%	162
2022 Q2	$23K	Buy	+80	New	+$23K	0.02%	146